EU Review Gets Under Way For Curative Vision Loss Gene Therapy

US Filing Of GenSight’s Lumevoq Will Come Later, In H2 2021

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".